# Intranasal Oxytocin for Frontotemporal Dementia

> **NCT03260920** · PHASE2 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 112 (estimated)

## Conditions studied

- Frontotemporal Dementia

## Interventions

- **DRUG:** Syntocinon

## Key facts

- **NCT ID:** NCT03260920
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-31
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03260920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03260920, "Intranasal Oxytocin for Frontotemporal Dementia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03260920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*